Immunophenotype of Epstein-Barr virus–specific cytotoxic T lymphocytes
| . | CD3+CD8+ . | CD3+CD4+ . | CD3+CD56+ . | CD3−CD56/16+ . | CD19+ . | TCR αβ . | TCR γδ . |
|---|---|---|---|---|---|---|---|
| Mean ± SD | 82 ± 18.8 | 16.4 ± 18.7 | 15.6 ± 13.4 | 1.2 ± 1.1 | 0 ± 0 | 93 ± 10.4 | 5.5 ± 11.9 |
| Range | 50-98 | 1.5-36 | 0.8-20 | 0-2.2 | 0 | 67-99 | 0.2-35 |
| . | CD3+CD8+ . | CD3+CD4+ . | CD3+CD56+ . | CD3−CD56/16+ . | CD19+ . | TCR αβ . | TCR γδ . |
|---|---|---|---|---|---|---|---|
| Mean ± SD | 82 ± 18.8 | 16.4 ± 18.7 | 15.6 ± 13.4 | 1.2 ± 1.1 | 0 ± 0 | 93 ± 10.4 | 5.5 ± 11.9 |
| Range | 50-98 | 1.5-36 | 0.8-20 | 0-2.2 | 0 | 67-99 | 0.2-35 |
Results are expressed as percentage of positive cells for surface markers by FACS analysis. The mean ± standard deviation and range of the 8 ex vivo–expanded, autologous, Epstein-Barr virus–specific T-cell lines are presented.